Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04447820 · ClinicalTrials.gov registry record · Phase 2
Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR
A Phase 2 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT04447820 is a Phase 2 study that has completed, run by Kowa Research Institute. The registered enrollment target is 96 participants.
The verdict
NCT04447820, a Phase 2 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
A study to evaluate the efficacy of K-877 extended release (ER) once daily (QD) compared to K-877 immediate release (IR) twice daily (BID).
Interventions
- DRUG K-877-ER (Dose A)
- DRUG K-877-ER (Dose B)
- DRUG K-877-IR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2020-06-10 |
| Est. Completion | 2020-12-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04447820
The ClinicalTrials.gov registry entry for NCT04447820 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which K-877-ER (Dose A) is the first listed.
NCT04447820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04447820 about?
NCT04447820 is a clinical study titled "Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR". A study to evaluate the efficacy of K-877 extended release (ER) once daily (QD) compared to K-877 immediate release (IR) twice daily (BID).
What is the current status of trial NCT04447820?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2020-06-10. Estimated completion is 2020-12-03.
What interventions are being tested in trial NCT04447820?
The interventions under investigation include: K-877-ER (Dose A) (DRUG), K-877-ER (Dose B) (DRUG), K-877-IR (DRUG).
Who is sponsoring clinical trial NCT04447820?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.